rs782660284

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_015107.3(PHF8):​c.2796_2798delCTC​(p.Ser933del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000886 in 1,207,312 control chromosomes in the GnomAD database, including 7 homozygotes. There are 282 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S932S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0050 ( 2 hom., 136 hem., cov: 22)
Exomes 𝑓: 0.00047 ( 5 hom. 146 hem. )

Consequence

PHF8
NM_015107.3 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.45

Publications

4 publications found
Variant links:
Genes affected
PHF8 (HGNC:20672): (PHD finger protein 8) The protein encoded by this gene is a histone lysine demethylase that preferentially acts on histones in the monomethyl or dimethyl states. The encoded protein requires Fe(2+) ion, 2-oxoglutarate, and oxygen for its catalytic activity. The protein has an N-terminal PHD finger and a central Jumonji C domain. This gene is thought to function as a transcription activator. Defects in this gene are a cause of syndromic X-linked Siderius type intellectual disability (MRXSSD) and over-expression of this gene is associated with several forms of cancer. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
PHF8 Gene-Disease associations (from GenCC):
  • syndromic X-linked intellectual disability Siderius type
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-53940367-TGAG-T is Benign according to our data. Variant chrX-53940367-TGAG-T is described in ClinVar as [Likely_benign]. Clinvar id is 445714.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00495 (550/111003) while in subpopulation AFR AF = 0.017 (519/30557). AF 95% confidence interval is 0.0158. There are 2 homozygotes in GnomAd4. There are 136 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PHF8NM_015107.3 linkc.2796_2798delCTC p.Ser933del disruptive_inframe_deletion Exon 21 of 22 ENST00000338154.11 NP_055922.1 Q9UPP1-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PHF8ENST00000338154.11 linkc.2796_2798delCTC p.Ser933del disruptive_inframe_deletion Exon 21 of 22 1 NM_015107.3 ENSP00000338868.6 Q9UPP1-2

Frequencies

GnomAD3 genomes
AF:
0.00496
AC:
550
AN:
110953
Hom.:
2
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0170
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00231
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000189
Gnomad OTH
AF:
0.00406
GnomAD2 exomes
AF:
0.00123
AC:
220
AN:
178336
AF XY:
0.000648
show subpopulations
Gnomad AFR exome
AF:
0.0155
Gnomad AMR exome
AF:
0.000740
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000226
GnomAD4 exome
AF:
0.000474
AC:
520
AN:
1096309
Hom.:
5
AF XY:
0.000404
AC XY:
146
AN XY:
361799
show subpopulations
African (AFR)
AF:
0.0163
AC:
430
AN:
26382
American (AMR)
AF:
0.000771
AC:
27
AN:
35001
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19353
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30175
South Asian (SAS)
AF:
0.0000186
AC:
1
AN:
53723
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40409
Middle Eastern (MID)
AF:
0.000243
AC:
1
AN:
4114
European-Non Finnish (NFE)
AF:
0.00000594
AC:
5
AN:
841132
Other (OTH)
AF:
0.00122
AC:
56
AN:
46020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00495
AC:
550
AN:
111003
Hom.:
2
Cov.:
22
AF XY:
0.00409
AC XY:
136
AN XY:
33287
show subpopulations
African (AFR)
AF:
0.0170
AC:
519
AN:
30557
American (AMR)
AF:
0.00230
AC:
24
AN:
10420
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2630
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3520
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2610
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5985
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000189
AC:
1
AN:
52883
Other (OTH)
AF:
0.00401
AC:
6
AN:
1498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00165
Hom.:
6
Bravo
AF:
0.00591

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 11, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 02, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 25, 2019
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 21, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

PHF8-related disorder Benign:1
Mar 17, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.4
Mutation Taster
=76/24
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782660284; hg19: chrX-53966800; API